ECMO: Back where we started, again

International Journal of Artificial Organs

Volumn 28, Issue 8, 2005, Pages 787-796

  Lynch, J E ^a   Clemson, L ^b   Deberry, B ^b   Zwischenberger, Joseph B ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; HEPARIN; HIRUDIN; NAFAMSTAT MESILATE; THROMBIN INHIBITOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL GAS; ARTIFICIAL VENTILATION; BLEEDING; BLOOD CLOTTING DISORDER; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EXTRACORPOREAL OXYGENATION; HEART ARREST; HEART ARRHYTHMIA; HUMAN; INFECTION; KIDNEY DISEASE; LUNG VASCULAR RESISTANCE; METABOLIC DISORDER; MORTALITY; MYOCARDITIS; NEUROLOGIC DISEASE; NEWBORN DISEASE; NONHUMAN; QUALITY CONTROL; RANDOMIZATION; RESPIRATORY FAILURE; RESUSCITATION; REVIEW; SURVIVAL; TREATMENT INDICATION;

EID: 27544452886     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502800804     Document Type: Review

References (46)

1. Kammemeyer K. Silicone rubber as a selective barrier. Indian Eng Chem 1957; 49: 1685.
2. Kolobow T, Bowman R. Construction and evaluation of an alveolar membrane artificial heart lung. Trans ASAIO 1963; 50: 29.
3. Hill D, O'Brien T, Muarry J, et al. Extracorporeal oxygenation for acute post traumatic respiratory failure (shock-lung syndrome) Use of the Bramson membrane lung. N Engl J Med 1972; 286: 629-34.
4. Bartlett R, Andrews A, Toomasian J, Haidue H, Gazzangia A. Extracorporeal Membrane Oxygenation (ECMO) in neonatal respiratory failure: 45 cases. Surgery 1982; 92: 425-53.
5. O'Rourke P, Krone R, Vacanti J, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study. Pediatr 1989; 84: 957-63.
6. Bartlett R, Roloff D, Cornell R, et al. Extracoporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatr 1985; 4: 479-87.
7. ECMO Registry of the Extracorporeal Life Support Organization (ELSO). Ann Arbor, Michigan: January, 2005.
8. Zapol W, Snider M, Hill J, et al. Extracorporeal membrane oxygenation in severe respiratory failure. JAMA 1979; 242: 2193-6.
9. Barefield E, Karle V, Phillips J, Carlo W. Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996; 129: 279-86.
10. The INOS Study Group: Inhaled nitric oxide for near term infants with respiratory failure. New Engl J Med 1997; 336: 602-5.
11. Davidson D, Barefield E, Kattwinkel J, Dudell G, Damask G, Straube R, Rhines J, and the INO/PPHN Study Group. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double masked, placebo controlled, dose response, multicenter study. Pediatr 1998; 101: 325-34.
12. Auten R, Notter R, Kendig J, Davis J, Shapiro D. Surfactant treatment of full-term newborns with respiratory failure. Pediatr 1991; 87: 101-07.
13. Khammash H, Perlman M, Wojtulewicz J, Dunn M. Surfactant therapy in full term neonates with severe respiratory failure. Pediatr 1993; 92: 135-9.
14. Findlay R, Taeusch H, Walther F. Surfactant replacement therapy for meconium aspiration syndrome. Pediatr 1996; 97: 48-52.
15. Lotze A, Mitchell B, Bulas D, Zola E, Shalwitz R, Gunkel J. Multicenter study of surfactant (beractant) use in the treatment of term in the treatment of term infants with severe respiratory failure. J Pediatr 1998; 132: 40-7.
16. Carlo W, Beoglos A, Chatburn R, Walsh M, Martin R. High-frequency jet ventilation in neonatal pulmonary hypertension. AJDC 1989; 124: 447-54.
17. Clark R, Yoder B, Sell M. Prospective randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994; 124: 447-54.
18. Goodman D, Green T. Extracorporeal life support for children with acute respiratory distress syndrome. In: Zwischenberger J, Steinhorn R, Bartlett R, eds. ECMO extracorporeal cardiopulmonary support in critical care. Extracorporeal Life Support Organization 2000; p. 421.
19. Spanier T, Chen J, Oz M. Selective anticoagulation with active site-blocked factor IXa suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998; 116: 860-9.
20. Hilt T, Bayat M. Drugs used to limit blood surface interactions. Crit Care Nurs Clin N Am 2002; 14: 7-16.
21. Hidchiko I, Koichi Y, Yukihiko N. Development of the oxygenator: Past present and future. Int J Artif Organs 2004; 7: 111-20.
22. Tadashi M, Tomohiro M, Shiniji K. Development of silicone rubber hollow fiber oxygenator for ECMO. Artif Organs 2003; 27: 1050-6.
23. Kihara S, Kawai A, Endo M, Koyangi H, Kurosawa H. Extracorporeal membrane oxygenation and left ventricular assist device: A case of double mechanical bridge. Heart Vessels 2002; 16: 164-6.
24. Marcolin R, Bombino M, Fumagalli R. Veno-venous ELS with heparin bonded circuits. Int J Artif Organs 1995; 18: 624-6.
25. Gravel M, Arenas J, Chenault R. Kidney transplantation from organ donors following cardiopulmonary death using extracorporeal membrane oxygenation support. Ann Transplant 2004; 9: 57-8.
26. Ludwig K, von Segesser. Heparin-bonded surfaces in Extracorporeal membrane oxygenation for cardiac support. Ann Thorac Surg 1996; 61; 330-5.
27. Johnston N, Wait M, Huber L. Agratoban in adult extracorporeal membrane oxygenation. J Extra Corpor Technol 2002; 34: 281-4.
28. Dager W, Gosselin R, Yoshikawa R, Owings J. Lepuridin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation. Ann Phamacother 2004; 38: 698-604.
29. Young G, Yonekawa K, Nakagawa P, Nugent D. Agratoban as an alternative to heparin in extracorporeal membrane oxygenation circuits. Perfusion 2004; 19: 283-8.
30. Sheehy E, Conrad SL, Brigham LE, et al. Estimating the number of potential organ donors in the United States. N Engl J Med 2003; 349: 667-74.
31. Conrad S, Zwischenberger J, Grier L, Bidani A. Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: A phase 1 clinical study. Intensive Care Med 2001; 27: 1340-51.
32. Bein T, Prasser C, Philipp A, Muller T, et al. Pumpless extracorporeal lung assist using arterio-venous shunt in severe ARDS. Experience with 30 cases. Anaesthesist 2004; 53: 813-9.
33. Jayroe J, Alpard S, Wang D, Deyo D, et al. Hemodynamic stability during arteriovenous carbon dioxide removal for adult respiratory distress syndrome: A prospective randomized outcomes study in adult sheep. ASAIO J 2001; 47: 211-4.
34. Gott V, Whiffen J, Dutton R. Heparin bonding on colloidal graphite surfaces. Science 1963; 142: 1297-8.
35. Muntean W. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Int J Artif Organs 1999; 23: 979-83.
36. Montoya J, Merz S, Bartlett R. Significant safety advantages gained with an improved pressure regulated pump. J Extra Corpor Technol 1996; 28: 71-8.
37. Zwischenberger JB, Nguyen TT, Upp JR Jr, Bush PE, Cox CS Jr, Delosh T, Broemling L. Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg 1994; 107: 838-48.
38. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5.
39. Nagaya M, Futamura M, Kato J, Niimi N, Fukuta S. Application of a new anticoagulant (nafamostat mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation - a preliminary report. J Pediatr Surg 1997; 32: 531-5.
40. UK Collaborative ECMO Trial Group. UK collaborative randomized trial of neonatal extracorporeal membrane oxygenation. Lancet 1996; 348: 75-81.
41. Lick S, Zwischenberger J. Artificial lung: Bench towards bedside. ASAIO J 2004; 50: 2-5.
42. Haft J, Montoya P, Alnajjar O, Posner S, et al. An artificial lung reduces pulmonary impedance and improves right ventricular efficiency in pulmonary hypertension. J Thorac Cardiovasc Surg 2001; 122: 1094-100.
43. Haft J, Bull J, Rose R, Katsra J, Grotberg J, Bartlett R, Hirschl R. Design of an artificial lung compliance chamber for pulmonary replacement. ASAIO J 2003; 49: 35-40.
44. Zwischenberger JB. Wang D. Lick SD. Deyo DJ. Alpard SK. Chambers SD. The paracorporeal artificial lung improves 5-day outcomes from lethal smoke/burn-induced acute respiratory distress syndrome in sheep. Ann Thorac Surg 74: 1011-6.
45. Lick SD, Zwischenberger JB, Alpard SK, Witt SA, Deyo DM, Merz SI. Development of an ambulatory artificial lung in an ovine survival model. ASAIO J 2001; 47: 486-91.
46. Lick SD, Zwischenberger JB, Wang D, Deyo DJ, Alpard SK, Chambers SD. Improved right heart function with a compliant inflow artificial lung in series with the pulmonary circulation. Ann Thorac Surg 2001; 72: 899-904.